Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273) |
---|
11/10/2011 | US20110275679 Flupirtine hydrochloride maleic acid cocrystal |
11/10/2011 | US20110275678 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics |
11/10/2011 | US20110275663 N-Acylthiourea and N-Acylurea Inhibitors of the Hedgehog Protein Signalling Pathway |
11/10/2011 | US20110275650 Methods and compositions related to targeting monoacylglycerol lipase |
11/10/2011 | US20110275645 Small Molecules for Inhibition of Protein Kinases |
11/10/2011 | US20110275638 Piperazine derivatives and their use as leptin receptor modulators |
11/10/2011 | US20110275615 Novel substituted amides, their preparation and use |
11/10/2011 | US20110275603 Novel immunomodulator and anti-inflammatory compounds |
11/10/2011 | US20110274773 Copper(I) Chloride Complex Of Nicotinic Acid And Pharmaceutical Compositions Containing The Same |
11/10/2011 | US20110272685 Materials for organic electroluminescence devices |
11/10/2011 | US20110272684 Materials for organic electroluminescence devices |
11/09/2011 | EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists |
11/09/2011 | EP2385037A1 Fungicidal phenoxyphenylhydrazine derivatives |
11/09/2011 | EP2131843B1 Process for the synthesis of glyt-1 inhibitors |
11/09/2011 | EP1987030B1 3 -deazapurine derivatives as tlr7 modulators |
11/09/2011 | EP1789390B1 Pyridyl inhibitors of hedgehog signalling |
11/09/2011 | EP1658263B9 Novel aminobenzophenone compounds |
11/09/2011 | CN1882542B 2-pyridone derivatives as neutrophil elastase inhibitors and their use |
11/09/2011 | CN102234505A Electrochromic material and preparation method thereof, and anti-dazzling automobile rear-vision mirror |
11/09/2011 | CN102234291A Bridged bis-Schiff-base-titanium complex, and synthesis method and application thereof |
11/09/2011 | CN102234271A Aryl (alkyl) amino dithio formate compounds, and preparation method and application thereof |
11/09/2011 | CN101899000B Method for synthesizing 3,5,6-trichloropyridine phenol sodium by liquid phase normal pressure direct catalytic chlorination |
11/09/2011 | CN101885702B Method for synthesizing 3,5,6-trichloropyridin 2 ol sodium by liquid-phase normal-pressure buffer solution method |
11/09/2011 | CN101759598B Tetracycline compound with amino acid amidine |
11/09/2011 | CN101343251B Thrombopoietin mimetics |
11/09/2011 | CN101300231B Pyridylsulfonamide derivatives, their manufacture and use as antineoplastic agents |
11/08/2011 | US8053451 Hydroxybenzoate salts of metanicotine compounds |
11/08/2011 | US8053445 Utilities of olefin derivatives |
11/08/2011 | US8053212 Non-standard nucleoside analogs with reduced epimerization |
11/08/2011 | CA2618393C Bis-aryl amide compounds and methods of use |
11/08/2011 | CA2596752C Derivatives of 4-demethylpenclomedine, use thereof and preparation thereof |
11/08/2011 | CA2509072C Saturated and unsaturated heteroarylcycloalkylmethyl-amines as antidepressants |
11/08/2011 | CA2452205C Activators for oligonucleotide synthesis |
11/08/2011 | CA2343414C Fc receptor modulators and uses thereof |
11/03/2011 | WO2011137431A2 Synthesis of four coordinated gold complexes and their applications in light emitting devices thereof |
11/03/2011 | WO2011137429A2 Synthesis of four coordinated palladium complexes and their applications in light emitting devices thereof |
11/03/2011 | WO2011137342A1 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activites |
11/03/2011 | WO2011137274A1 Pharmaceutical compositions comprising n-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-l-(4-fluorophenyl)-2-oxo- 1,2-dihydropyridine-3 -carboxamide |
11/03/2011 | WO2011136484A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same |
11/03/2011 | WO2011136308A1 Prophylactic or therapeutic agent for diseases associated with pains in urinary organs |
11/03/2011 | WO2011136292A1 Novel amide derivative and use thereof as medicine |
11/03/2011 | WO2011136155A1 Novel organic compound and organic light-emitting device including the same |
11/03/2011 | WO2011136095A1 Treatment agent for decomposition of chemical substance which comprises persulfuric acid salt and silver complex, and method for decomposition of chemical substance using same |
11/03/2011 | WO2011134963A1 Method for producing substituted pyridin-2-one |
11/03/2011 | WO2011089576A3 Novel compositions for reducing abeta 42 production and their use in treating alzheimer's disease (ad) |
11/03/2011 | WO2011082400A3 Modulators of immunoinhibitory receptor pd-1, and methods of use thereof |
11/03/2011 | WO2010074747A8 Stable insecticide compositions and methods for producing same |
11/03/2011 | US20110269970 Phenethanolamine Derivatives for Treatment of Respiratory Diseases |
11/03/2011 | US20110269785 Substituted 2-Aminoacetamides and the Use Thereof |
11/03/2011 | US20110269761 Arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments |
11/03/2011 | US20110269760 Tubulin inhibitors |
11/03/2011 | US20110269751 Heterocyclic nitrogenous or oxygenous compounds with insecticidal activity formed from dialdehydes and their preparation and uses thereof |
11/03/2011 | US20110269747 Polyarylcarboxamides useful as lipid lowering agents |
11/03/2011 | US20110269722 Prodrugs containing novel bio-cleavable linkers |
11/03/2011 | US20110269709 Prodrugs containing novel bio-cleavable linkers |
11/03/2011 | US20110269677 Oligomer-Protease Inhibitor Conjugates |
11/03/2011 | DE102010028362A1 Herstellverfahren Manufacturing process |
11/03/2011 | CA2800569A1 Cyclopropyl dicarboxamides and analogs exhibiting anti-cancer and anti-proliferative activities |
11/03/2011 | CA2797604A1 Method for producing substituted pyridin-2-one |
11/02/2011 | EP2383814A1 Organic electroluminescent device |
11/02/2011 | EP2383813A1 Light-emitting element material and light-emitting element |
11/02/2011 | EP2383259A1 New pyridone derivatives with MCH antagonistic activity and medicaments comprising these compounds |
11/02/2011 | EP2383258A1 Method for rapidly methylating heteroaromatic ring aryl and method for producing pet tracer |
11/02/2011 | EP2382215A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof |
11/02/2011 | EP2382195A1 Substituted amidine compounds for combating animal pests |
11/02/2011 | EP2382190A1 Toluidine sulfonamides and their use as-inhibitors |
11/02/2011 | EP2382189A1 Toluidine sulfonamides and their use |
11/02/2011 | EP2197841B1 Guanidine-containing compounds useful as muscarinic receptor antagonists |
11/02/2011 | EP1838674B9 Heteroaryl sulfonamides and ccr2 |
11/02/2011 | CN102232067A Nicotinamide derivatives |
11/02/2011 | CN102229589A N-{4'-substituted piperazine-1-sulfonylmethylalkyl}-N-hydroxyfomamide compounds as metalloproteinase inhibitors |
11/02/2011 | CN102229560A Cis-nitenpyram compound including 1,3-dicarbonyl, preparation method and use |
11/01/2011 | USRE42889 α- and β- amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
11/01/2011 | US8049037 Sphingosine-1-phosphate (S1P) receptor antagonists and methods for use thereof |
11/01/2011 | US8049015 Heteroaryl antagonists of prostaglandin D2 receptors |
11/01/2011 | US8048911 Melanin eliminator preparation |
11/01/2011 | US8048898 Inhibitor of binding of S1P1 |
11/01/2011 | US8048897 Cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
11/01/2011 | US8048873 Synergistic pharmaceutical combination for the prevention or treatment of diabetes |
11/01/2011 | CA2663408C Substituted pyridylmethyl bicyclocarboxyamide compounds |
11/01/2011 | CA2557877C Vapor phase catalytic chlorination of .beta.-picoline |
11/01/2011 | CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds |
11/01/2011 | CA2476586C Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
11/01/2011 | CA2458534C Phenethanolamine derivatives for treatment of respiratory diseases |
11/01/2011 | CA2446193C 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
11/01/2011 | CA2409741C Tnf-.alpha. production inhibitors |
10/27/2011 | WO2011133442A1 Novel synthesis for thiazolidinedione compounds |
10/27/2011 | WO2011132712A1 Novel hydroxamic acid derivative |
10/27/2011 | WO2011132171A1 Nitric oxide releasing prodrugs of therapeutic agents |
10/27/2011 | WO2011132034A1 A method of synthezising the complex [fe(nns)2] active against the malaria parasite plasmodium falciparum |
10/27/2011 | WO2011132033A1 A method of synthesizing a complex [cu(nns)cl] active against the malaria parasite plasmodium falciparum |
10/27/2011 | WO2011132032A1 A method of synthesizing the complex [zn(nns)2] active against the malaria parasite plasmodium |
10/27/2011 | WO2011132031A1 A method of synthesizing the complex [ni (nns)2] active against the malaria parasite plasmodium falciparum |
10/27/2011 | WO2011132030A1 A method of synthesizing a complex [mn (nns)2] active against the malaria parasite plasmodium falciparum |
10/27/2011 | WO2011132029A1 A method of synthesizing a complex [co (nns) 2] active against the malaria parasite plasmodium |
10/27/2011 | WO2011132028A1 A method of synthesis of cdl2 complex with high biological activity against at least chloroquine resistant strain of the malaria parasite plasmodium falciparum |
10/27/2011 | WO2011131135A1 Heteroaryl (alkyl) dithiocarbamate compounds, preparation methods and uses thereof |
10/27/2011 | WO2011100829A8 Bifunctional chelating agents |
10/27/2011 | US20110263849 Method for rapidly methylating heteroaromatic arene and method for producing tracer for use in pet |
10/27/2011 | US20110263845 Method for manufacturing heterocycle substituted pyridine derivatives |